| Code | 9547D | ||||||||||
| MA number | EU/1/22/1625/001 | ||||||||||
| Product Form: | tbl flm 30 (20x150 mg+10x100 mg) (blis.OPA/Al/PVC) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Pfizer Europe MA EEIG, Belgium | ||||||||||
| Therapeutic Class: | 42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister OPA/Al/PVC | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 28.01.2022 |
| Validity: | 24.02.2028 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
infolist_Paxlovid_Shelf Life extension_24 mes_ dalsie sarze_04-10-2023.pdf
|
| Dokument: |
DHPC_Paxlovid_21.03.2024.pdf
|
| Safety feature | Yes |
| Data update: | 14.10.2024 |
